Trade Onconova Therapeutics, Inc. - ONTX CFD
Add to favourite- Summary
- Historical Data
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.98 |
Open | 0.93 |
1-Year Change | 32.86% |
Day's Range | 0.77 - 0.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 2, 2024 | 0.95 | 0.02 | 2.15% | 0.93 | 0.97 | 0.75 |
Apr 1, 2024 | 0.98 | -0.01 | -1.01% | 0.99 | 1.01 | 0.98 |
Mar 28, 2024 | 0.99 | 0.02 | 2.06% | 0.97 | 1.04 | 0.97 |
Mar 27, 2024 | 0.94 | 0.04 | 4.44% | 0.90 | 0.95 | 0.89 |
Mar 26, 2024 | 0.85 | 0.02 | 2.41% | 0.83 | 0.89 | 0.83 |
Mar 25, 2024 | 0.83 | 0.00 | 0.00% | 0.83 | 0.85 | 0.82 |
Mar 22, 2024 | 0.84 | 0.02 | 2.44% | 0.82 | 0.85 | 0.82 |
Mar 21, 2024 | 0.82 | 0.00 | 0.00% | 0.82 | 0.83 | 0.80 |
Mar 20, 2024 | 0.81 | 0.00 | 0.00% | 0.81 | 0.83 | 0.80 |
Mar 19, 2024 | 0.81 | -0.03 | -3.57% | 0.84 | 0.85 | 0.81 |
Mar 18, 2024 | 0.86 | 0.05 | 6.17% | 0.81 | 0.91 | 0.81 |
Mar 15, 2024 | 0.82 | -0.05 | -5.75% | 0.87 | 0.87 | 0.80 |
Mar 14, 2024 | 0.87 | -0.04 | -4.40% | 0.91 | 0.91 | 0.83 |
Mar 13, 2024 | 0.91 | 0.03 | 3.41% | 0.88 | 0.94 | 0.88 |
Mar 12, 2024 | 0.90 | -0.03 | -3.23% | 0.93 | 0.95 | 0.87 |
Mar 11, 2024 | 0.93 | -0.02 | -2.11% | 0.95 | 0.95 | 0.90 |
Mar 8, 2024 | 0.91 | 0.02 | 2.25% | 0.89 | 1.00 | 0.89 |
Mar 7, 2024 | 0.87 | -0.02 | -2.25% | 0.89 | 0.89 | 0.86 |
Mar 6, 2024 | 0.88 | -0.01 | -1.12% | 0.89 | 0.89 | 0.85 |
Mar 5, 2024 | 0.84 | -0.08 | -8.70% | 0.92 | 0.92 | 0.80 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Onconova Therapeutics, Inc. Company profile
About Onconova Therapeutics Inc
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing products for patients with cancer. The Company has created a targeted anti-cancer agent designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its pipeline includes two clinical-stage programs. ON 123300 product candidate is a multi-kinase inhibitor targeting cyclin dependent kinase (CDK 4/6) and other tyrosine kinasesto to drive tumor proliferation. Its another product candidate Oral Rigosertib in combination with a PD-1 inhibitor targeting patients with K-Ras mutated non-small cell lung cancer (NSCLC).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Onconova Therapeutics Inc revenues decreased 2% to $226K. Net loss decreased 36% to $16.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Change in fair value of warrant liab. increase from $208K (expense) to $321K (income).
Equity composition
Common Stock $0.01 Par, 07/13, 80M Auth., 20,062,996 Issd,. Insiders Owns Approx.76.99%
Industry: | Biopharmaceuticals |
375 Pheasant Run
NEWTOWN
PENNSYLVANIA 18940
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com